BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 16436576)

  • 1. Guidelines for interactions between clinical faculty and the pharmaceutical industry: one medical school's approach.
    Coleman DL; Kazdin AE; Miller LA; Morrow JS; Udelsman R
    Acad Med; 2006 Feb; 81(2):154-60. PubMed ID: 16436576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attitudes of medical school faculty toward gifts from the pharmaceutical industry.
    Banks JW; Mainous AG
    Acad Med; 1992 Sep; 67(9):610-2. PubMed ID: 1520424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conflict-of-interest policies for investigators in clinical trials.
    Lo B; Wolf LE; Berkeley A
    N Engl J Med; 2000 Nov; 343(22):1616-20. PubMed ID: 11096170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishing policies for the relationship between industry and clinicians: lessons learned from two academic health centers.
    Coleman DL
    Acad Med; 2008 Sep; 83(9):882-7. PubMed ID: 18728449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Financial conflicts of interest in physicians' relationships with the pharmaceutical industry--self-regulation in the shadow of federal prosecution.
    Studdert DM; Mello MM; Brennan TA
    N Engl J Med; 2004 Oct; 351(18):1891-900. PubMed ID: 15509824
    [No Abstract]   [Full Text] [Related]  

  • 6. University physician-researcher conflicts of interest: the inadequacy of current controls and proposed reform.
    Maatz CT
    High Technol Law J; 1992; 7():137-88. PubMed ID: 11659962
    [No Abstract]   [Full Text] [Related]  

  • 7. Development of residency program guidelines for interaction with the pharmaceutical industry. Education Council, Residency Training Programme in Internal Medicine, Department of Medicine, McMaster University, Hamilton, Ont.
    CMAJ; 1993 Aug; 149(4):405-8. PubMed ID: 8348422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does growing up with a physician influence the ethics of medical students' relationships with the pharmaceutical industry? The cases of the US and Poland.
    Makowska M
    BMC Med Ethics; 2017 Aug; 18(1):49. PubMed ID: 28797266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions between emergency medicine programs and the pharmaceutical industry.
    Keim SM; Mays MZ; Grant D
    Acad Emerg Med; 2004 Jan; 11(1):19-26. PubMed ID: 14709424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conflict of interest policies at Belgian medical faculties: Cross-sectional study indicates little oversight.
    Bechoux L; De Vleeschouwer O; Vanheuverzwijn C; Verhegghen F; Detiffe A; Colle F; Fallon C; Thoreau F
    PLoS One; 2021; 16(2):e0245736. PubMed ID: 33566836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Professional organizations and healthcare industry support: ethical conflict?
    Hazlet TK; Sullivan SD
    Camb Q Healthc Ethics; 1994; 3(2):236-44; discussion 244-56. PubMed ID: 8049771
    [No Abstract]   [Full Text] [Related]  

  • 12. Industry relationships between physicians and professional medical associations: corrupt or essential?
    Smith CD; MacFadyen B
    Surg Endosc; 2010 Feb; 24(2):251-3. PubMed ID: 20087748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ethics of the medical-pharmaceutical relationship.
    Vashi NA; Latkowski JA
    Clin Dermatol; 2012; 30(2):188-91. PubMed ID: 22330662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of medical students' reports of interactions with the pharmaceutical and medical device industries and medical school policies and characteristics: a cross-sectional study.
    Yeh JS; Austad KE; Franklin JM; Chimonas S; Campbell EG; Avorn J; Kesselheim AS
    PLoS Med; 2014 Oct; 11(10):e1001743. PubMed ID: 25314155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between physicians and the pharmaceutical industry: what does the literature say?
    Lexchin J
    CMAJ; 1993 Nov; 149(10):1401-7. PubMed ID: 8221424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The need for a transparent, ethical, and successful relationship between academic scientists and the pharmaceutical industry: a view of the Group for the Respect of Ethics and Excellence in Science (GREES).
    Bruyere O; Kanis JA; Ibar-Abadie ME; Alsayed N; Brandi ML; Burlet N; Cahall DL; Chines A; Devogelaer JP; Dere W; Goel N; Hughes N; Kaufman JM; Korte S; Mitlak BH; Niese D; Rizzoli R; Rovati LC; Reginster JY
    Osteoporos Int; 2010 May; 21(5):713-22. PubMed ID: 20238101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guidelines on gifts to physicians from industry: an update.
    American Medical Association. Council on Ethical and Judicial Affairs
    Food Drug Law J; 1992; 47(4):445-58. PubMed ID: 11654909
    [No Abstract]   [Full Text] [Related]  

  • 18. A perspective on commercial relationships between ophthalmology and industry.
    Jampol LM; Packer S; Mills RP; Day SH; Lichter PR;
    Arch Ophthalmol; 2009 Sep; 127(9):1194-202. PubMed ID: 19752430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Managing conflicts of interest: who, and how?
    Katelaris A
    Med J Aust; 2012 Apr; 196(7):427. PubMed ID: 22509861
    [No Abstract]   [Full Text] [Related]  

  • 20. Professional medical associations and their relationships with industry: a proposal for controlling conflict of interest.
    Rothman DJ; McDonald WJ; Berkowitz CD; Chimonas SC; DeAngelis CD; Hale RW; Nissen SE; Osborn JE; Scully JH; Thomson GE; Wofsy D
    JAMA; 2009 Apr; 301(13):1367-72. PubMed ID: 19336712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.